ArticleCancers2026

Revisiting the OGIPRO Trial: Dynamic Electronic Patient-Reported Outcomes Compared with EQ-5D-5L in HER2-Positive Breast Cancer.

Anatol Aicher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.